Lettera aperta a Schillaci-Bernini
Risultati per: Svelato il tallone d’Achille della malattia di Parkinson
Questo è quello che abbiamo trovato per te
I tumori sono la malattia più temuta per il 70% degli italiani
Rapporto Censis, poco più del 60% crede che il cancro si possa prevenire
I tumori sono la malattia più temuta per il 70% degli italiani
Poco più del 60% crede che il cancro si possa prevenire
Mattarella: 'Nessuna malattia è mai così rara da non meritare cure'
Messaggio del presidente della Repubblica nella Giornata Mondiale delle Malattie Rare
Gaslini e UniGe, Scoperta una nuova malattia del neurosviluppo
E’ associata alla mutazione genetica
Svelato il tallone d’Achille della malattia di Parkinson
Malattia di Chron, una dieta può portare alla remissione
La sperimentazione condotta con successo dal Meyer
Linee guida sulla malattia epatica associata all’alcol
Farmaci per la disfunzione erettile collegati a un ridotto rischio di malattia di Alzheimer
Tumore del pancreas, scoperto come la malattia sfugge alle cure
Usa un trucco genetico. Studio apre a nuove cure
Intermittent Wolff-Parkinson-White Syndrome Mimicking a Ventricular Tachycardia
This case report describes a patient in their 50s with a history of pneumoconiosis and chronic obstructive pulmonary disease who presented to the emergency department with sudden onset shortness of breath.
Oms: 'Il Covid è stata la prima malattia X, può succedere ancora'
Tedros a Davos: ‘Lo ripetiamo non per creare il panico ma per prepararsi’
Colpito da malattia rarissima 13enne salvato al Meyer di Firenze
Affetto dermatomiosite giovanile con complicanza, rischiava vita
Ministero sanità Malawi, 10.000 morti per malattia nel 2023
Malaria resta maggiore causa di morte infantile
Tumore dell'ovaio, un test scova la malattia con anni di anticipo
Studio, la diagnosi precoce possibile con l’analisi sul Pap test
Implementation and the effects of a Parkinson Network Therapy (PaNTher) on activities of daily living and health-related quality of life in Parkinsons disease patients: study protocol of an mixed-method observational cohort study in outpatient care
Introduction
Parkinson’s disease (PD) represents the fastest growing neurodegenerative disease with an increasing prevalence worldwide. It is characterised by complex motor and non-motor symptoms that lead to considerable disability. Specialised physiotherapy has been shown to benefit patients with PD. The Parkinson Netzwerk Therapie (PaNTher) was created to improve access to specialised physiotherapy tailored to care priorities of PD patients. This study aims to evaluate the effectiveness, acceptability and needs of the PaNTher network by neurologists and physiotherapists involved in the network in outpatient care.
Methods and analysis
This is a mixed-method, prospective, pragmatic non-randomised cohort study of parallel groups, with data collection taking place in Bavaria, Germany, between 2020 and 2024. Patients with PD insured by the Allgemeine Ortskrankenkasse Bayern (AOK Bayern) living in Bavaria will be recruited for study participation by network partners. Patients in the intervention group must reside in Munich or the surrounding area to ensure provision of specialised physiotherapy in close proximity to their place of residence. Controls receive care as usual. Six and 12 months after baseline, all patients receive a follow-up questionnaire. Mixed-effect regression models will be used to examine changes in impairment of activities of daily living and quality of life of patients with PD enrolled in the programme over time compared with usual care. Qualitative interviews will investigate the implementation processes and acceptability of the PaNTher network among neurologists and physiotherapists. The study is expected to show that the PaNTher network with an integrative care approach will improve the quality and effectiveness of the management and treatment of patients with PD.
Ethics and dissemination
The study has been approved by the ethics committee at the medical faculty of the Ludwig-Maximilians-University Munich (20-318). Results will be published in scientific, peer-reviewed journals and presented at national and international conferences.